Overview

Study of NaQuinate in Healthy Volunteers

Status:
Unknown status

Trial end date:
2020-05-30

Target enrollment:

Participant gender:

Summary

Phase 1, randomised, double-blind, placebo-controlled study of NaQuinate in healthy subjects after single ascending oral (PO) doses and multiple ascending PO doses.

Phase:

Phase 1

Details

Lead Sponsor:

Haoma Medica Limited

Collaborator:

Parexel